Skip to main content
. 2016 Nov 18;95(46):e5201. doi: 10.1097/MD.0000000000005201

Figure 3.

Figure 3

Kaplan–Meier analysis of the differences in the risk of metabolic syndrome between the treatment groups (P > 0.05 by the log-rank test).